Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Angelo Ruggiero, Luca Potestio, Fabrizio Martora, Alessia Villani, Rosita Comune & Matteo Megna. (2023) Bimekizumab treatment in patients with moderate to severe plaque psoriasis: a drug safety evaluation. Expert Opinion on Drug Safety 22:5, pages 355-362.
Read now
Read now
Marie Hamilton Larsen, Yndis Staalesen Strumse, Marit Helen Andersen, Christine Raaheim Borge & Astrid Klopstad Wahl. (2021) Associations between disease education, self-management support, and health literacy in psoriasis. Journal of Dermatological Treatment 32:6, pages 603-609.
Read now
Read now
Ciro Romano, Sergio Esposito, Roberta Ferrara & Giovanna Cuomo. (2020) Choosing the most appropriate biologic therapy for Crohn’s disease according to concomitant extra-intestinal manifestations, comorbidities, or physiologic conditions. Expert Opinion on Biological Therapy 20:1, pages 49-62.
Read now
Read now
Katie E Benjegerdes, Kimberly Hyde, Dario Kivelevitch & Bobbak Mansouri. (2016) Pustular psoriasis: pathophysiology and current treatment perspectives. Psoriasis: Targets and Therapy 6, pages 131-144.
Read now
Read now
Yue Zhao & Wei Lai. (2014) Patient considerations and targeted therapies in the management of psoriasis in Chinese patients: role of ustekinumab. Patient Preference and Adherence 8, pages 865-872.
Read now
Read now
Articles from other publishers (17)
Aanchal Singh & Nimisha Srivastava. (2023) An Insight into the Potential of Flavonoids and Furanocoumarins in the
Treatment of Psoriasis. Current Bioactive Compounds 19:10.
Crossref
Crossref
Emanuela Zagni, Luca Bianchi, Gabriella Fabbrocini, Salvatore Corrao, Annamaria Offidani, Luca Stingeni, Antonio Costanzo, Giovanni Pellacani, Ketty Peris, Federico Bardazzi, Giuseppe Argenziano, Silvana Ruffolo, Paolo Dapavo, Carlo Carrera, Maria Concetta Fargnoli, Aurora Parodi, Marco Romanelli, Piergiorgio Malagoli, Marina Talamonti, Matteo Megna, Massimo Raspanti, Matteo Paolinelli, Katharina Hansel, Alessandra Narcisi, Andrea Conti, Clara De Simone, Marco Adriano Chessa, Alina De Rosa, Eugenio Provenzano, Michela Ortoncelli, Chiara Moltrasio, Rosaria Fidanza, Martina Burlando, Annalisa Tonini, Francesca Maria Gaiani, Lucia Simoni, Alessandro Zullo, Martina Fiocchi & Delia Colombo. (2021) A real-world economic analysis of biologic therapies for moderate-to-severe plaque psoriasis in Italy: results of the CANOVA observational longitudinal study. BMC Health Services Research 21:1.
Crossref
Crossref
James J. Campbell, Karen Ebsworth, Linda S. Ertl, Jeffrey P. McMahon, Yu Wang, Simon Yau, Venkat R. Mali, Vicky Chhina, Alice Kumamoto, Shirley Liu, Ton Dang, Dale Newland, Israel F. Charo, Penglie Zhang, Thomas J. Schall & Rajinder Singh. (2019) Efficacy of Chemokine Receptor Inhibition in Treating IL-36α–Induced Psoriasiform Inflammation. The Journal of Immunology 202:6, pages 1687-1692.
Crossref
Crossref
J.J. Wu, A.A. Joshi, S.P. Reddy, M. Batech, A. Egeberg, O. Ahlehoff & N.N. Mehta. (2018) Anti-inflammatory therapy with tumour necrosis factor inhibitors is associated with reduced risk of major adverse cardiovascular events in psoriasis. Journal of the European Academy of Dermatology and Venereology 32:8, pages 1320-1326.
Crossref
Crossref
Aparna P. Sajja, Aditya A. Joshi, Heather L. Teague, Amit K. Dey & Nehal N. Mehta. (2018) Potential Immunological Links Between Psoriasis and Cardiovascular Disease. Frontiers in Immunology 9.
Crossref
Crossref
Juan Marcos Gonzalez. (2018) Evaluating Risk Tolerance from a Systematic Review of Preferences: The Case of Patients with Psoriasis. The Patient - Patient-Centered Outcomes Research 11:3, pages 285-300.
Crossref
Crossref
Lipeng Tang, Songmin He, Xieqi Wang, Hongying Liu, Ying Zhu, Bing Feng, Zuqing Su, Wei Zhu, Bo Liu, Fangfang Xu, Chutian Li, Jie Zhao, Xirun Zheng, Chuanjian Lu & Guangjuan Zheng. (2018)
Cryptotanshinone
reduces psoriatic epidermal hyperplasia via inhibiting the activation of STAT3
. Experimental Dermatology 27:3, pages 268-275.
Crossref
Crossref
Marco Bonesi, Monica R. Loizzo, Francesco Menichini & Rosa Tundis. 2018. Immunity and Inflammation in Health and Disease. Immunity and Inflammation in Health and Disease
281
294
.
I V Kozlova, Yu N Myalina, L P Lipina & A L Bakulev. (2017) Optimization of therapy for hepatobiliary disorders in psoriatic patients. Terapevticheskii arkhiv 89:12-2, pages 204-210.
Crossref
Crossref
A.D. Cohen, J.J. WuL. Puig, S. Chimenti, R. Vender, M. Rajagopalan, R. Romiti, C. de la Cruz, L. Skov, C. Zachariae, H.S. Young, P. Foley, J.M. van der Walt, L. Naldi, E.P. Prens & A. Blauvelt. (2017) Biosimilars for psoriasis: worldwide overview of regulatory guidelines, uptake and implications for dermatology clinical practice. British Journal of Dermatology 177:6, pages 1495-1502.
Crossref
Crossref
Jörg Christoph Prinz. (2017) Autoimmune aspects of psoriasis: Heritability and autoantigens. Autoimmunity Reviews 16:9, pages 970-979.
Crossref
Crossref
Tiago Torres. (2017) Selective Interleukin-23 p19 Inhibition: Another Game Changer in Psoriasis? Focus on Risankizumab. Drugs 77:14, pages 1493-1503.
Crossref
Crossref
G. Micali, F. Lacarrubba, C. Santagati, C. G. Egan, M. R. Nasca & M. L. Musumeci. (2015) Clinical, ultrasound, and videodermatoscopy monitoring of psoriatic patients following biological treatment. Skin Research and Technology 22:3, pages 341-348.
Crossref
Crossref
Shan Jiang, Taylor E. Hinchliffe & Tianfu Wu. (2015) Biomarkers of An Autoimmune Skin Disease—Psoriasis. Genomics, Proteomics & Bioinformatics 13:4, pages 224-233.
Crossref
Crossref
Giulia Ganzetti. (2015) Non-alcoholic fatty liver disease and psoriasis: So far, so near. World Journal of Hepatology 7:3, pages 315.
Crossref
Crossref
M. Alan Menter & Christopher E.M. Griffiths. (2015) Psoriasis. Dermatologic Clinics 33:1, pages 161-166.
Crossref
Crossref
Juan Guinea-ViniegraMaría JiménezHelia B. SchonthalerRaquel NavarroYolanda DelgadoMaría José Concha-GarzónErwin TschachlerSusanna ObadEsteban DaudénErwin F. Wagner. (2014)
Targeting
miR-21
to Treat Psoriasis
. Science Translational Medicine 6:225.
Crossref
Crossref